CompaniesArtivion
Artivion logo

Artivion

active
Kennesaw, GA, United States
Founded 1984
Website
About

Tissues, surgical adhesives, additional devices

Areas of Focus

Categories

Medical ImplantSurgical DeviceSoutheastern U.S.
Team (20)
Amy D. Horton, CPA
Amy D. Horton, CPA
Vice President, Chief Accounting OfficerArtivion, Inc.Kennesaw, Georgia
Artivion
executive
Andrew M. Green
Andrew M. Green
Vice President, Regulatory AffairsArtivion, Inc.Kennesaw, Georgia
Artivion
executive
Anthony Semedo
Anthony Semedo
Retired Senior Vice President & President of Japan OperationsMedtronic
Artivion
executive
Daniel J. Bevevino
Daniel J. Bevevino
Retired Vice President and Chief Financial OfficerRespironics, Inc.Murrysville, Pennsylvania
Artivion
executive
Elizabeth A. Hoff
Elizabeth A. Hoff
Consultant and FounderHoff Professional Services
Artivion
team_member
Florian Tyrs
Florian Tyrs
Vice President, Global OperationsArtivion, Inc.Hechingen, DE
Artivion
executive
View all 20 team members →
Clinical Trials (17)
View all

Total Trials

17

As Lead Sponsor

11

As Collaborator

6

Total Enrollment

1,848

By Phase

NA: 15PHASE3: 1

By Status

COMPLETED: 7UNKNOWN: 4TERMINATED: 4NOT_YET_RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline17 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
Today
NCT02359994
NCT03035643
NCT03397251
NCT05174767
NCT07089576
Hover over trial bars to see details

Recent Trials

NCT07089576Lead Sponsor
Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA
NANot yet recruiting
132 participants
Started: Sep 30, 2025 · Completed: Jun 30, 2032
NCT05598736Lead Sponsor
Performance and Long-term Safety of FlowOx2.0™, Multiple Sclerosis, Spasticity and Pain
NAUnknown
60 participants
Started: Nov 4, 2022 · Completed: Dec 31, 2023
NCT05562453Lead Sponsor
Performance and Long-term Safety of FlowOx2.0™ in Patients With Multiple Sclerosis - Impact on Spasticity and Pain
NAUnknown
56 participants
Started: Oct 4, 2022 · Completed: Aug 15, 2023
NCT05174767Lead Sponsor
PERSEVERE- a Trial to Evaluate AMDS in Acute DeBakey Type I Dissection
NAActive, not recruiting
115 participants
Started: May 27, 2022 · Completed: Dec 6, 2029
NCT05314868Lead Sponsor
Retrospective Evaluation of Photo-oxidized Decellularized Bovine Pericardium in Cardiac Repair or Reconstruction Surgery
N/ATerminated
10 participants
Started: Mar 31, 2022 · Completed: Nov 30, 2022
View all 17 trials →
Funding History (20)
8-K
Sep 29, 2025
Filing
8-K
Sep 15, 2025
Filing
8-K
Aug 11, 2025
Filing
8-K
Aug 7, 2025
Filing
8-K
May 29, 2025
Filing
8-K
May 16, 2025
Filing
8-K
May 14, 2025
Filing
8-K
May 5, 2025
Filing
DEFA14A
Apr 1, 2025
Filing
DEF 14A
Apr 1, 2025
Filing
Locations (1)
Headquarters
Kennesaw, GA, United States
Map

Loading map...